Oddzial Chorob Wewnetrznych
About Oddzial Chorob Wewnetrznych
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
1
Novartis Pharmaceuticals
1
Clinical Trials at Oddzial Chorob Wewnetrznych
During the past decade, Oddzial Chorob Wewnetrznych conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
2003-06-01
2008-07-01
Completed
551
Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
2009-02-01
2011-03-01
Completed
1,988
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Oddzial Chorob Wewnetrznych"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Oddzial Chorob Wewnetrznych
According to Clinical.Site data, the most researched conditions in "Oddzial Chorob Wewnetrznych" are
"Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Oddzial Chorob Wewnetrznych" in a lesser frequency.
Clinical Trials Intervention Types at Oddzial Chorob Wewnetrznych
Most popular intervention types in "Oddzial Chorob Wewnetrznych" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Exenatide (AC2993)" (1 trials), "Insulin glargine" (1 trials), "Metformin" (1 trials), "Placebo" (1 trials) and "Sitagliptin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Oddzial Chorob Wewnetrznych
The vast majority of trials in "Oddzial Chorob Wewnetrznych" are
2 trials for "All" genders.
Clinical Trials Status at Oddzial Chorob Wewnetrznych
Currently, there are NaN active trials in "Oddzial Chorob Wewnetrznych".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Oddzial Chorob Wewnetrznych,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Oddzial Chorob Wewnetrznych, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".